Muiesan P, Dhawan A, Novelli M, Mieli-Vergani G, Rela M, Heaton N D
Department of Child Health, King's College Hospital, London, United Kingdom.
Transplantation. 2000 Jun 15;69(11):2323-6. doi: 10.1097/00007890-200006150-00017.
Liver dysfunction is a well-recognized complication of intestinal failure in children. Advances in total parenteral nutrition (TPN) have allowed these children to survive while their intestinal tract gradually adapts. Unfortunately TPN may lead to cholestatic liver disease particularly in the young children. Progression of liver disease is associated with a poor prognosis and is an indication for small bowel transplantation. We report our experience of orthotopic liver transplantation in four children with short gut and sequential liver and small bowel transplantation in one child. All children had TPN-related liver failure. Causes of intestinal failure included necrotising enterocolitis (n=2), gastroschisis (n=1), intestinal atresia (n=1), and megacystic, microcolon syndrome (n=1). At the time of liver transplantation the children's mean age was 10.9 months (2.5-24) and weight 6.7 kg (4.8-10.1). The mean serum bilirubin was 522 micromol/liter (299-823), aspartate transaminase 423 IU/liter (49-1024) and international normalized ratio 2.8 (2-3.9). There were two deaths both from respiratory failure secondary to adenovirus pneumonia including the child who received a sequential small bowel transplant. Three children with isolated liver grafts are alive and off TPN at 20 months (mean) follow up (range 6-35). Isolated orthotopic liver transplantation has a role in selected children with intestinal failure, particularly those with short but normally functioning gut and progressing with satisfactory intestinal adaptation but developing liver disease. Those children with TPN-related liver disease and unadapted gut or irreversible intestinal disease need combined liver and small bowel transplantation. Sequential small bowel transplantation is feasible after orthotopic liver transplantation and may provide an option for the child with terminal liver and small bowel failure.
肝功能障碍是儿童肠衰竭一种公认的并发症。全胃肠外营养(TPN)的进展使这些儿童得以存活,同时其肠道逐渐适应。不幸的是,TPN可能导致胆汁淤积性肝病,尤其是在幼儿中。肝病进展与预后不良相关,是小肠移植的指征。我们报告了4例短肠患儿原位肝移植以及1例患儿序贯肝和小肠移植的经验。所有患儿均有TPN相关肝衰竭。肠衰竭的病因包括坏死性小肠结肠炎(n = 2)、腹裂(n = 1)、肠闭锁(n = 1)和巨膀胱、小结肠综合征(n = 1)。肝移植时,患儿的平均年龄为10.9个月(2.5 - 24个月),体重6.7千克(4.8 - 10.1千克)。平均血清胆红素为522微摩尔/升(299 - 823),天冬氨酸转氨酶423国际单位/升(49 - 1024),国际标准化比值为2.8(2 - 3.9)。有2例死亡,均死于腺病毒肺炎继发的呼吸衰竭,包括接受序贯小肠移植的患儿。3例接受单纯肝移植的患儿在平均20个月(范围6 - 35个月)的随访时存活且停用了TPN。单纯原位肝移植在部分肠衰竭患儿中具有作用,尤其是那些肠道短但功能正常且肠道适应进展良好但发生肝病的患儿。那些患有TPN相关肝病且肠道未适应或有不可逆肠道疾病的患儿需要联合肝和小肠移植。原位肝移植后序贯小肠移植是可行的,可为终末期肝和小肠衰竭患儿提供一种选择。